Boehringer Ingelheim is set to launch VAXXITEK® HVT+IBD+H5 in Egypt in February 2025, a trivalent vaccine that protects against Marek’s disease, Infectious Bursal Disease, and H5 avian influenza. Designed for hatchery application, it effectively bridges the immunity gap in chicks. This vaccine integrates the COBRA technology to enhance coverage against various H5 strains, marking a significant advance in poultry health management.
Boehringer Ingelheim has announced the launch of its new trivalent poultry vaccine, VAXXITEK® HVT+IBD+H5, set for February 2025. This innovative vaccine provides comprehensive protection against three significant poultry diseases: Marek’s disease, Infectious Bursal Disease (Gumboro), and H5 avian influenza. This advancement is pivotal for enhancing the resilience of Egypt’s poultry industry against prevalent health threats.
Designed for hatchery administration, the VAXXITEK® vaccine targets H5 avian influenza—an infectious, zoonotic disease that disrupts poultry production and trade. The vaccine offers timely protection for chicks by bridging the immunity gap created as maternal antibodies decrease and active immunity is established. This proactive measure is essential for more effective disease prevention from the outset.
Marek’s disease causes high mortality and severe health issues in poultry, while Infectious Bursal Disease results in productivity challenges. Vaccination against these diseases is common; however, VAXXITEK® HVT+IBD+H5 is the first vaccine globally to incorporate protection against H5 avian influenza alongside these critical illnesses in a single shot.
The vaccine’s effectiveness is backed by Boehringer Ingelheim’s COBRA technology, which optimally designs a unique antigen sequence. This advancement broadens the vaccine’s coverage against various H5 avian influenza strains and enhances its overall efficacy, representing a significant technological advancement in avian health.
Taoufik Rawi, Head of Franchise, Poultry at Boehringer Ingelheim, stated, “The launch of VAXXITEK® HVT+IBD+H5 is another step forward in avian influenza prevention regarding both coverage and convenience.” This reveals the company’s dedication to helping poultry producers maintain flock health amid persistent threats.
The vaccine features DIVA technology, which differentiates vaccinated birds from naturally infected ones, facilitating effective disease outbreak management. Dr. David Swayne, former USDA Laboratory Director, commented on the ongoing challenges posed by H5 avian influenza, emphasizing the critical role of vaccination in protection strategies for poultry health.
Industry leaders highlighted the vaccine’s regional significance. According to Waleed El Mashak, Head of Animal Health IMETA at Boehringer Ingelheim, “The launch of VAXXITEK® HVT+IBD+H5 represents a critical advancement for poultry farmers across IMETA.” The vaccine’s introduction in Egypt reflects a strong commitment to sustainable poultry farming.
Magdy Hassan, President of the Egyptian Veterinary Syndicate, described the launch of VAXXITEK® as a milestone, providing poultry farmers a robust solution for flock immunity. Mahmoud El Mahdy, Country Head of Animal Health for North, East, and West Africa at Boehringer Ingelheim, called the vaccine a game-changer, enhancing market stability and promoting international trade.
As Egypt’s poultry sector is vital for food security and the economy, the introduction of VAXXITEK® HVT+IBD+H5 is poised to deliver significant benefits to both producers and consumers. This innovative vaccine is expected to lead to improved disease control and sustainable production practices in the country’s poultry industry.
The launch of VAXXITEK® HVT+IBD+H5 by Boehringer Ingelheim represents a landmark development in poultry vaccination, providing comprehensive protection against important diseases affecting birds. Its innovative DIVA technology allows precise disease management while the integration of multiple vaccines into one product boosts efficacy and accessibility for producers. This launch is expected to significantly enhance the resilience of Egypt’s poultry sector, ensuring food security and economic stability.
Original Source: www.dailynewsegypt.com
